According to a paper published by Amway researchers in Clinical, Cosmetics and Investigational Dermatology, anecdotal evidence abounds for the therapeutic uses of non-psychotropic cannabidiol (CBD) in skin and health applications. However, clinical efficacy and underlying mechanisms of action have yet to be identified and confirmed.
As such, the authors reviewed the latest tangible evidence in the literature (as of the paper’s publication on Dec. 8, 2020) related to 12 application areas for CBD. They considered emerging evidence as well as conflicting and/or plausible findings in each area; following is an editorialized overview with select examples from the review. See the full open access paper for more details.
Published by Global Cosmetic Industry, December 30, 2020
The Latin America skincare products market is experiencing a paradigm shift, with consumers placing greater…
While people discuss self-love or vanity, in the clandestine operating rooms of Latin America hundreds…
The labelling of personal care products, cosmetics and perfumes in Brazil follows specific Anvisa regulations,…